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Material and Methods: We modeled the CBCT system which 
built-in Varian Clinac iX with full-fan and half-fan filter by 
using the Monte Carlo code(MCNPX 2.7.0). By acquiring the 
measured data with EBT3 films for PDD(percent-depth dose) 
and beam profile for open, full-fan and half-fan filter in 
static mode, we verified that simulated data was coincided 
with measured data for spectrum. The assessment of 
absorbed dose of each organ during the CBCT scanning was 
performed with ORNL(Oak Ridge National Laboratory)-male-
MIRD(Medical Internal Radiation Dose) phantom. In this study, 
we set the scan range adapted for the CBCT scan conditions 
and then the absorbed dose of each organ was evaluated 
applying a half-fan filter. In that time, the CBCT scan range 
was changed by modulating the Y jaw from 16 cm to 8 cm at 
intervals of 2 cm and we verified the difference of absorbed 
dose of each organ according to CBCT scan range. 
 
Results: For CBCT scan in thorax, the absorbed dose of heart 
and lung were reduced for 46.6~32.1 mGy and 75~47.4 mGy, 
respectively, and the other side lung was reduced for 
31.7~19.1 mGy. As the scan range was decreased at intervals 
of 2 cm, the absorbed dose in lung was reduced up to 10 %. In 
the case of heart, the absorbed dose was reduced drastically. 
For prostate, absorbed dose of bladder, sigmoid colon and 
testes showed dose reduction for 61.4~41.7 mGy, 50.4~38.8 
mGy and 81.1~45.4 mGy, respectively. In the case of penis, 
the absorbed dose was reduced from 81.1 to 45.4 mGy. 
 
Conclusion: We evaluated the change of organ dose 
according to CBCT scan range with Monte Carlo code MCNPX 
and male-MIRD phantom. In the result, we verified the organ 
dose can be different about 30~40% according to changes of 
CBCT scan range. We thought this study can be used in 
optimization for radiation exposure to patients, usefully. 
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Purpose or Objective: Defining patient specific Cone beam 
computed tomography (CBCT) acquisition parameter to 
optimize breast imaging dose 
 
Material and Methods: Since last few years, in-room 
volumetric imaging systems which include MV computed 
tomography (CT) and MV or kV cone-beam computed 
tomography (CBCT) are being used for greater soft tissue 
definition and improved target localization. This technology 
helps in escalating target dose while decreasing normal tissue 
doses. This improves the therapeutic ratio of radiotherapy. 
Intense IGRT protocols are adopted to reduce the PTV margin 
and to understand changes happening during course of 
treatment. Additional imaging dose due to intense IGRT 
protocol is concern for deterministic and non-deterministic 
radiobiology effect. In this study we measure imaging dose to 
breast in thorax region from Varian on board imaging CBCT 
Three OSL dosimeters were placed on the contra lateral 
breast. One dosimeter was placed at centre and other two 
dosimeters were placed 5 cm apart from centrally placed 
dosimeter. Low dose thorax imaging protocol was used for all 
measurements. All CBCT acquisitions were performed with 
fixed geometry for all measurements. CBCT images were 
acquired with half-fan cone with bow tie filtration, source-
detector distance of 150 cm, 0.25 cm slice thickness, 
transversal field-of view (FOV) of 25 cm, and a scan length of 
18 cm giving a longitudinal FOV of approximately 17.5 cm. 
Scans were performed with 200 degree rotation of gantry. To 
get a reasonable signal, dosimeters were irradiated during 
five consecutive treatment fractions for the CBCT imaging 
protocols. For same patients CBCT images were acquired 
using modified low dose thorax protocol also. In modified 
Low dose thorax protocol tube current was reduced from 
20mA to 10 mA. Dose to contra lateral breast was measured 
in same three positions 
 
Results: The absorbed dose per fraction using the CBCT for 
standard low-dose thorax protocol was 9 ± 0.30 mSv; for the 
“Modified Low dose thorax” protocol it was 4.8 ± 0.21 mSv; it 
can be seen that the “Modified Low dose thorax” protocol 
results in a reduction of 51% in absorbed dose compared to 
the standard low-dose thorax protocol. It was also noticed 
that, by changing acquisition parameters quality of both 
scans were comparable. 
 
Conclusion: It is important to have patient specific 
acquisition protocol rather than vendor supplied protocol so 
that imaging dose can be optimized. 
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Purpose or Objective: Out-of-field doses during radiotherapy 
treatments (RT) are associated with an increased risk of 
second malignant neoplasms in cancer survivors. The purpose 
of this work is to evaluate the impact, in terms of peripheral 
dose (PD), that new techniques for lung cancer such us 
stereotactic body radiotherapy (SBRT), modulated beams 
(IMRT and VMAT) and FFF would have in comparison to more 
traditional plans (3DCFRT).  
 
Material and Methods: Self-developed models [1,2] were 
used for neutron and photon peripheral dose (NPD and PPD, 
respectively) estimation to 12 organs, associated to lung 
treatments delivered using 3 linacs: Siemens Primus (6&15 
MV), Elekta Synergy (6 MV) and Varian TrueBeam (6,10&15 
MV; FFF mode available for the first two). Facilities were 
previously characterized in terms of neutron production [3] 
and photon leakage.  
17 plans were generated for a lung cancer case (60 cGy to 
100%).Different PTVs were used for conventional and 
stereotactic treatments (factor of 20 between both volumes). 
Results were compared to values from the literature [4] 
where PD studies were done but by terms of direct 
measurements of only photon component for few external 
points. 
 
Results: Figure (a) shows estimated NPD and PPD to some 
selected organs for SBRT treatments in 6 and 10 MV, 
including FF and FFF modes. Figure (b) shows average PPD to 
the same representative out-of-field organs (mSv) for 4 
studied techniques, considering all the linacs and plans.  
 
ESTRO 35 2016                                                                                                                                                    S751 
________________________________________________________________________________ 
 
 
As an example, differences in PPD and NPD, for 3D-CRT and 
IMRT in low and high energies, are shown in the table. Taking 
into account leakage, field size and MU, an average increase 
in PPD values of 8.6% and 12.6% has been obtained for Varian 
and Elekta linacs with respect to Siemens, when considering 
for the here studied 3D-CRT treatment in 6 MV. However, a 
decrease in 19% was noticed when using FFF mode.  
 
 
Conclusion: Lower PD in SBRT cases could be due to the 
smaller size of ITV vs. conventional PTV. Our results are in 
agreement with previous clinical studies [4]. Additionally, we 
have quantified the advantage of reduced PD when using FFF 
mode. However, this study only considers PD while ignoring 
the impact of radiobiological effect due to the dose per 
fraction. 
The slight differences found between techniques (3D-CRT, 
IMRT and VMAT) are due to the simple case chosen (in terms 
of target geometry). Nevertheless, the tendency shows 
higher values for VMAT and IMRT. Thus, further studies are 
desirable to extrapolate these results to complex cases.  
Neutron contributes in a small percentage to global PD, this 
becomes especially relevant if 15 MV represents only a part 
of the total treatment.  
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Purpose or Objective: The use of Cone-Beam computed 
Tomography (CBCT) is progressively increasing in 
radiotherapy treatments, but additional doses induced are 
not well quantified and could amplify the risk for patients to 
develop a second cancer. There is a need, expressed by the 
medical physics community, to develop tools to estimate, 
report and potentially help reducing CBCT doses. We hence 
developed a Monte Carlo (MC) model for the XVI kV-CBCT 
system. The dosimetric and geometric accuracy of the 
simulated beams was evaluated by comparisons with 
measurements in a water tank, and x-ray energy spectra 
acquisitions. Before clinical use, the model requires an 
evaluation in anthropomorphic phantoms in which were 
inserted OSL NanoDots (Landauer). The purpose of the 
present study is to develop an accurate dosimetric protocol 
taking into account for OSL energy dependence in keV energy 
range.  
 
Material and Methods: A MC model of the XVI was developed 
using the PENELOPE code. The dosimetric and geometrical 
evaluation of the beam MC models was performed by 
comparing simulations with lateral and depth-dose profiles 
measured using a PTW Farmer-type chamber, and on-axis 
energy spectra measured with a CdTe detector. These 
comparisons were performed at 120, 100 and 80 kVp, and for 
different filtration/collimation couples. For OSL 
measurements, the first step was to perform, in different 
beam qualities, in-air cross-calibrations with a PTW Farmer-
type chamber. At this energy range, OSL exhibit strong 
energy dependence, so the signal needs to be corrected for 
the spectral variations between calibration and measurement 
conditions. Thus, to ensure accurate dose measurements, a 
correction method was developed using calculated spectra. 
The dosimetric protocol was validated by performing dose 
profiles with OSL inserted in a PMMA tube submerged in 
water. Preliminary comparisons with XVI model were made 
with acquisitions in a home-made heterogeneous phantom 
consisting of a water tank equipped with PMMA, bone and 
lung equivalent inserts. 
 
Results: Experimental and simulated lateral and depth-dose 
profiles, and energy spectra, are in excellent agreement (Fig 
1A).These results validate that the MC model accurately 
reproduces the dosimetric and geometric properties of the 
XVI beams. The uncorrected OSL profiles in the PMMA tube 
over-estimate by 15 % the calculated doses. However, energy 
corrected measurements are matching the simulations and 
the differences not exceed 7.5 % (Fig 1B and 1C). Table 1 
presents doses measured at different points in the 
heterogeneous phantom and discrepancies not exceed 11.3 %. 
 
 
 
 
Conclusion: The dosimetric protocol developed for OSL 
allows accurate measurements of imaging doses, and will be 
then used to validate the dose calculation tool in pre-clinical 
conditions. Preliminary results obtained in the home-made 
phantom highlight the accuracy of XVI MC model. Further 
validations are on-going in anthropomorphic phantoms. 
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